According to studies about the effect of astatines on infectious diseases, most of studies have focused on such diseases as sepsis, pneumonia, and influenza. Relying on a widespread study, it has recently revealed the advantages of receiving Astatines by the patients suffering of sepsis. A clinical trial of several centers in Japan has shown noticeable decrease of death caused by Influenza and pneumonia among consumers of an average dosage of Astatine.